Virginia Board of Medicine Practitioner Information

Home Icon Home

Search Icon Search

Disclaimer Icon Disclaimers

Links Icon Links

Glossary Icon Glossary

Help Icon Questions


Printer Friendly Version Printer Icon
 

Susan Edwards Beatty, MD

LICENSE # 0101235628
 
Issue Date: 10/10/2003
Expiration Date: 11/30/2024
Status: Current Active


General InformationEducationCertifications & Practice AreaInsuranceHonors & AwardsAcademic Appointments & PublicationsProceedings, Actions & ConvictionsPaid Claims
Unless otherwise indicated, this information has been self-reported and has not been verified by the Board of Medicine.


Academic Appointments
Last Updated 11/12/2022
None Reported
Academic Appointments - Non-US
Last Updated 11/12/2022
None Reported
Publications
(up to ten in the last five years)
Last Updated 11/12/2022
Long-term Safety and Effectiveness of Zafirlukast in School-Aged Children
JACI
Volume: S24
Date: 01 2000

Zafirlukast Improves Asthma Control in Children Treated with and without Inhaled Corticosteroids
Pediatric Research
Volume: 47
Date: 01 2000

Safety and tolerance of zafirlukast (Accolate(TM)) in school-aged children
Pediatric Pulmonology
Suppl 23
Date: 01 2001

Specific blockade of shared epitope antigen presentation by the HLA-DRB1 antagonist, AZD2315, in patients with active rheumatoid arthritis (RA): Results of
Arthritis and Rheumatism
48(9) Suppl S:S229
Date: 09 2003

Baseline (BL) radiographic characteristics and severe pulmonary hemorrhage (SPH) in bevacizumab (BV) - treated non-small cell lung cancer (NSCLC) patient (pt) subpopulations from the ARIES observational cohort study (OCS)
J Clin Oncology
28 (suppl abstract 7619)
Date: 07 2010

Clinical outcomes for special populations of patients with advanced non-small cell lung cancer (NSCLC); Results from ARIES, a bevacizumab (BV) observational cohort study.
J Clin Oncology
28 suppl abstract 7618)
Date: 07 2010